Yuan Ping, Bao Chun-Ling, Dong Gui-Rong
Acupuncture-Moxibustion Department of Tongji Hospital Affiliated to Shanghai Tongji University, Shanghai 200442, China.
Zhongguo Zhen Jiu. 2012 Jul;32(7):577-81.
To verify the safety of penetrating acupuncture at the head points for cerebral hemorrhage at the acute stage.
Sixty cases of cerebral hemorrhage at the acute stage were selected and randomized into a western medication group and a head-point group, 30 cases in each one. In the western medication group, the anti-cranial pressure and anti-blood pressure program was administered with the conventional intravenous infusion of Sodium Nitroprusside, Mannite, etc. In the head-point group, on the basis of the treatment as the western medication group, the penetrating acupuncture at the head points was supplemented. For consciousness disturbance, Taiyang (EX-HN 5), Benshen (GB 13) and penetrating needling from Shenting (GV 24) to Shangxing (GV 23) were selected. For headache, the penetrating needling was adopted from Shangxing (GV 23) to Yintang (EX-HN 3) and from Fengchi (GB 20) to Fengchi (GB 20). For disturbance of urination and defecation, the penetrating needling was adopted from Baihui (GV 20) to Sishencong (EX-HN 1). For aphasia, the penetrating needling was adopted from Fengfu (GV 16) to Yamen (GV 15), etc. For facial paralysis, the penetrating needling from Dicang (ST 4) to Jiache (ST 6) and Xiaguan (ST 7) were selected. For paralysis, the penetrating needling was adopted from Baihui (GV 20) to Taiyang (EX-HN 5), etc. Before and after treatment, the changes in cerebral hemorrhagic volume, the results of blood, urine and stool routine examination, the situations of the life indices such as heart, liver and kidney functions, blood pressure, respiration and heart rate were observed, as well as the impacts on ECG.
The cranial CT sania cn indicated that the rate of the basic and significant absorption of hematoma was 80.0% (24/30) in the head-point group, which was superior to 56.7% (17/30) in the western medication group (P < 0.05). Before and after treatment, the results of blood, urine and stool routine examination and the life indices such as blood pressure, respiration and heart rate were all in the normal scope for the patients in the head-point group (all P > 0.05). There were no any abnormal changes in liver and kidney functions. In the head-point group, the abnormality rate of ECG was lower obviously than that in the western medication group [16.7% (5/30) vs 43.3% (13/30), P < 0.05].
The penetrating acupuncture at the head points is safe in the treatment of cerebral hemorrhage at the acute stage.
验证头部穴位透刺治疗脑出血急性期的安全性。
选取60例脑出血急性期患者，随机分为西药组和头部穴位组，每组30例。西药组采用常规静脉输注硝普钠、甘露醇等进行降颅压、降血压治疗。头部穴位组在西药组治疗的基础上，加用头部穴位透刺治疗。意识障碍者选取太阳（EX-HN 5）、本神（GB 13），采用神庭（GV 24）透刺至囟会（GV 23）；头痛者采用囟会（GV 23）透刺至印堂（EX-HN 3）、风池（GB 20）透刺至风池（GB 20）；大小便失禁者采用百会（GV 20）透刺至四神聪（EX-HN 1）；失语者采用风府（GV 16）透刺至哑门（GV 15）等；面瘫者选取地仓（ST 4）透刺至颊车（ST 6）、下关（ST 7）；肢体瘫痪者采用百会（GV 20）透刺至太阳（EX-HN 5）等。观察治疗前后脑出血量的变化、血尿常规及大便常规检查结果、心、肝、肾功能、血压、呼吸、心率等生命体征指标变化以及对心电图的影响。
头颅CT显示，头部穴位组血肿基本吸收及明显吸收的比例为80.0%（24/30），优于西药组的56.7%（17/30）（P<0.05）。头部穴位组治疗前后血尿常规及大便常规检查结果、血压、呼吸、心率等生命体征指标均在正常范围内（均P>0.05），肝肾功能无异常改变。头部穴位组心电图异常率明显低于西药组[16.7%（5/30）比43.3%（13/30），P<0.05]。
头部穴位透刺治疗脑出血急性期安全有效。
